TAKARA BIO INC. Board Supports Tender

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 13, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

TAKARA BIO INC. Board Supports Tender Offer, Recommends Shareholders Tender

Source disclosure: February 13, 2026 TAKARA BIO INC. [4974.T] TOKYO, Feb 13 (Kyodo) - Takara Bio Inc., listed on the Tokyo Stock Exchange's Prime Market under code number 4974, announced Monday that its board of directors has endorsed and recommended to shareholders the tender offer by its controlling shareholder, Hattori Holdings Corp. The resolution was made during a board meeting held today, where the company expressed support for the public offering initiated by Hattori Holdings